| P50 | author | Boris Kovatchev | Q90782245 |
| | Claudio Cobelli | Q49943995 |
| P2093 | author name string | Eric Renard | |
| P2860 | cites work | [Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin | Q72787246 |
| | Metabolic and hormonal responses to exercise in type 1 diabetic patients during continuous subcutaneous, as compared to continuous intraperitoneal, insulin infusion | Q73350397 |
| | Interstitial glucose concentration and glycemia: implications for continuous subcutaneous glucose monitoring | Q73634197 |
| | Continuous intraperitoneal insulin infusion partly restores the glucagon response to hypoglycaemia in type 1 diabetic patients | Q73771198 |
| | Clinical utility of the continuous glucose monitoring system | Q74255119 |
| | AUTOMATION CONTROL OF BLOOD SUGAR. I. A SERVOMECHANISM FOR GLUCOSE MONITORING AND CONTROL | Q76823522 |
| | Comparison of metabolic deterioration between insulin analog and regular insulin after a 5-hour interruption of a continuous subcutaneous insulin infusion in type 1 diabetic patients | Q78115008 |
| | The role of new technology in the early detection of hypoglycemia | Q94368805 |
| | A physiological model of glucose-insulin interaction in type 1 diabetes mellitus | Q28250044 |
| | Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies | Q28741005 |
| | Comparison of the numerical and clinical accuracy of four continuous glucose monitors | Q30370423 |
| | Anticipating the next meal using meal behavioral profiles: a hybrid model-based stochastic predictive control algorithm for T1DM. | Q30427062 |
| | Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results | Q30429989 |
| | Hypoglycemia Prevention via Pump Attenuation and Red-Yellow-Green “Traffic” Lights Using Continuous Glucose Monitoring and Insulin Pump Data | Q30430888 |
| | Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events | Q30431605 |
| | Diabetes: Models, Signals, and Control | Q30434551 |
| | Control to range for diabetes: functionality and modular architecture | Q30434937 |
| | Run-to-run tuning of model predictive control for type 1 diabetes subjects: in silico trial | Q30434940 |
| | Model predictive control of type 1 diabetes: an in silico trial | Q30437991 |
| | Continuous Glucose Sensors: Continuing Questions about Clinical Accuracy | Q30437997 |
| | Modeling of Calibration Effectiveness and Blood-to-Interstitial Glucose Dynamics as Potential Confounders of the Accuracy of Continuous Glucose Sensors during Hyperinsulinemic Clamp | Q30438611 |
| | Peculiarities of the continuous glucose monitoring data stream and their impact on developing closed-loop control technology | Q30439262 |
| | In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes | Q30439654 |
| | The subcutaneous route to insulin-dependent diabetes therapy | Q32042368 |
| | The intravenous route to blood glucose control | Q32042388 |
| | Improved Glycemic Control in Poorly Controlled Patients with Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring | Q56093368 |
| | Relationship Between Interstitial And Blood Glucose in Type 1 Diabetes Patients: Delay And The Push-Pull Phenomenon Revisited | Q58886211 |
| | Peritoneal and subcutaneous absorption of insulin in type I diabetic subjects | Q63411905 |
| | Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia | Q66885252 |
| | Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump | Q67470970 |
| | The Artificial Beta Cell - A Continuous Control of Blood Sugar by External Regulation of Insulin Infusion (Glucose Controlled Insulin Infusion System) | Q69357792 |
| | A preliminary trial of the programmable implantable medication system for insulin delivery | Q69683362 |
| | Kinetic modeling of the glucoregulatory system to improve insulin therapy | Q69913310 |
| | Evaluation of alternative model structures of metabolic systems: two case studies on model identification and validation | Q70488977 |
| | Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients | Q71025142 |
| | A mathematical model for the control mechanism of free fatty acid-glucose metabolism in normal humans | Q71470410 |
| | Development of a miniaturized glucose monitoring system by combining a needle-type glucose sensor with microdialysis sampling method. Long-term subcutaneous tissue glucose monitoring in ambulatory diabetic patients | Q72133558 |
| | A probabilistic approach to glucose prediction and insulin dose adjustment: description of metabolic model and pilot evaluation study | Q72429437 |
| | Wearable artificial endocrine pancrease with needle-type glucose sensor | Q72539664 |
| | French multicentre experience of implantable insulin pumps. The EVADIAC Study Group. Evaluation of Active Implants in Diabetes Society | Q72669452 |
| | Clinical trial of programmable implantable insulin pump for type I diabetes | Q33203229 |
| | An online self-tunable method to denoise CGM sensor data | Q33509942 |
| | Modeling the error of continuous glucose monitoring sensor data: critical aspects discussed through simulation studies | Q33532319 |
| | Closed-loop insulin delivery using a subcutaneous glucose sensor and intraperitoneal insulin delivery: feasibility study testing a new model for the artificial pancreas | Q33556720 |
| | Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes | Q33873106 |
| | Control of Blood Glucose in Diabetics using an Artificial Pancreas* | Q34175044 |
| | Preventing hypoglycemia using predictive alarm algorithms and insulin pump suspension | Q34302184 |
| | Can interstitial glucose assessment replace blood glucose measurements? | Q34316031 |
| | Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes | Q34550195 |
| | A bihormonal closed-loop artificial pancreas for type 1 diabetes | Q34564238 |
| | Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial | Q34616506 |
| | Evaluation of factors affecting CGMS calibration | Q34700508 |
| | Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy | Q35026130 |
| | Hypoglycemia Warning Signal and Glucose Sensors: Requirements and Concepts | Q35544390 |
| | Closed-loop insulin delivery-the path to physiological glucose control | Q35637319 |
| | Continuous glucose monitoring: roadmap for 21st century diabetes therapy | Q36108412 |
| | Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial | Q36351118 |
| | Continuous glucose monitoring and closed-loop systems | Q36367034 |
| | The accuracy of the CGMS in children with type 1 diabetes: results of the diabetes research in children network (DirecNet) accuracy study | Q36473851 |
| | Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system. | Q36666262 |
| | Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM. A multicenter study. The EVADIAC Study Group. Evaluation dans le Diabète du Traitement par Implants Actifs | Q36681057 |
| | Insulin underdelivery from implanted pumps using peritoneal route. Determinant role of insulin pump compatibility | Q36823772 |
| | A Run-to-Run Control Strategy to Adjust Basal Insulin Infusion Rates in Type 1 Diabetes | Q36838643 |
| | The accuracy of the Guardian RT continuous glucose monitor in children with type 1 diabetes | Q36983511 |
| | Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM). | Q37242652 |
| | Physiologic insulin delivery with insulin feedback: A control systems perspective | Q37776811 |
| | Devices for insulin administration | Q37977224 |
| | An Artificial Endocrine Pancreas | Q39323639 |
| | Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring | Q39517601 |
| | The artificial pancreas: how sweet engineering will solve bitter problems | Q40256085 |
| | A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas | Q40441940 |
| | Hypoglycemia prediction and detection using optimal estimation | Q40441945 |
| | Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. | Q40480952 |
| | Intraperitoneal insulin administration produces a positive portal-systemic blood insulin gradient in unanesthetized, unrestrained swine | Q41598309 |
| | Quantitative estimation of insulin sensitivity | Q41600825 |
| | Enhanced, simplified glucose sensors: long-term clinical application of wearable artificial endocrine pancreas | Q41696791 |
| | Interstitial fluid glucose dynamics during insulin-induced hypoglycaemia | Q42480892 |
| | GIM, simulation software of meal glucose-insulin model | Q42597813 |
| | Accuracy requirements for a hypoglycemia detector: an analytical model to evaluate the effects of bias, precision, and rate of glucose change | Q42598157 |
| | Modular artificial beta-cell system: a prototype for clinical research | Q42598847 |
| | Feasibility of automating insulin delivery for the treatment of type 1 diabetes | Q42604696 |
| | Lower Rate of Initial Failures and Reduced Occurrence of Adverse Events with a New Catheter Model for Continuous Subcutaneous Insulin Infusion: Prospective, Two-Period, Observational, Multicenter Study | Q42920462 |
| | Enhanced accuracy of continuous glucose monitoring by online extended kalman filtering | Q43101367 |
| | Comparison of blood glucose stability and HbA1C between implantable insulin pumps using U400 HOE 21PH insulin and external pumps using lispro in type 1 diabetic patients: a pilot study | Q43971411 |
| | Glycemic control with closed-loop intraperitoneal insulin in type I diabetes | Q44117421 |
| | The development of Biostator, a Glucose Controlled Insulin Infusion System (GCIIS) | Q44386588 |
| | A microdialysis technique for continuous subcutaneous glucose monitoring in diabetic patients (part 1) | Q44416704 |
| | Physiological differences between interstitial glucose and blood glucose measured in human subjects | Q44526994 |
| | Comparison of peripheral and portal (via the umbilical vein) routes of insulin infusion in IDDM patients | Q44620942 |
| | Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor | Q44631829 |
| | Comparison of accuracy and safety of the SEVEN and the Navigator continuous glucose monitoring systems | Q44657711 |
| | A continuous glucose sensor based on wired enzyme technology -- results from a 3-day trial in patients with type 1 diabetes | Q44665859 |
| | Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system | Q44874898 |
| | A novel approach to mitigating the physiological lag between blood and interstitial fluid glucose measurements | Q45208967 |
| | The extended Kalman filter for continuous glucose monitoring | Q45288050 |
| | Run-to-run control of meal-related insulin dosing | Q45288053 |
| | Detection of hypoglycemia with continuous interstitial and traditional blood glucose monitoring using the FreeStyle Navigator Continuous Glucose Monitoring System. | Q45987814 |
| | Insulin antibody responses after long-term intraperitoneal insulin administration via implantable programmable insulin delivery systems. | Q45992238 |
| | Comparison of peripheral and portal routes of insulin infusion by a computer-controlled insulin infusion system (artificial endocrine pancreas) | Q46084129 |
| | Continuous glucose monitoring and intensive treatment of type 1 diabetes | Q46380752 |
| | The MiniMed continuous glucose monitoring system | Q46663660 |
| | Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas | Q46770123 |
| | A dual-rate Kalman filter for continuous glucose monitoring | Q46942656 |
| | Meal simulation model of the glucose-insulin system | Q46958119 |
| | Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps | Q48008296 |
| | A model-based algorithm for blood glucose control in type I diabetic patients | Q49087508 |
| | OmniPod Insulin Management System: patient perceptions, preference, and glycemic control. | Q51140234 |
| | Run-to-run control of blood glucose concentrations for people with Type 1 diabetes mellitus. | Q51184704 |
| | Integral-based filtering of continuous glucose sensor measurements for glycaemic control in critical care. | Q51214759 |
| | Metabolic response to three years of continuous, basal rate intravenous insulin infusion in type II diabetic patients. | Q51636876 |
| | Pharmacokinetics of insulin infused intra-peritoneally via portable pumps. | Q51638068 |
| | The evaluation of the ability of closed-loop glycemic control device to maintain the blood glucose concentration in intensive care unit patients. | Q51737984 |
| | A simulation study on a self-tuning portable controller of blood glucose. | Q52404055 |
| | Validation of mathematical models of complex endocrine-metabolic systems. A case study on a model of glucose regulation | Q52704624 |
| | Evaluation of Portal/Peripheral Route and of Algorithms for Insulin Delivery in the Closed-Loop Control of Glucose in Diabetes - A Modeling Study | Q52708975 |
| | Comparison of algorithms for the closed-loop control of blood glucose using the artificial beta cell. | Q52733982 |
| | Evaluation of exogenous insulin homoeostasis by the artificial pancreas in insulin-dependent diabetes | Q52812905 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivatives | Q6937225 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreas | Q9618 |
| | type-1 diabetes | Q124407 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 2672-2682 | |
| P577 | publication date | 2011-11-01 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | Artificial pancreas: past, present, future | |
| P478 | volume | 60 | |